Julia Marie Eastland Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

Julia Marie Eastland is CEO & President of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 28,500 shares of ZNTL, which is worth approximately $46,455. The most recent transaction as insider was on Jan 31, 2025, when has been sold 28,500 shares (Common Stock) at a price of $1.73 per share, resulting in proceeds of $49,305. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.5K

n/a 3M change

n/a 12M change

Total Value Held $46,455

JULIA MARIE EASTLAND Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 31 2025	BUY Open market or private purchase	$49,305 $1.73 p/Share	28,500 Added 50.0%	28,500 Common Stock

Also insider at

HARP

Harpoon Therapeutics, Inc. Healthcare

President and CEO

DVAX

DYNAVAX TECHNOLOGIES CORP Healthcare

GRAY

GRAYBUG VISION, INC. Healthcare

Director

LNTH

Lantheus Holdings, Inc. Healthcare

Director

JME